HomeIndustriesBanks & FinanceNvidia (NVDA) To Launch Chips For Chinese Market & Eli Lilly (LLY) Gains Weight Loss Drug Approval

Nvidia (NVDA) To Launch Chips For Chinese Market & Eli Lilly (LLY) Gains Weight Loss Drug Approval

Nvidia (NVDA) is to launch three chips for the Chinese market. NVDA stock is up 225% year-to-date. According to Reuters, NVDA’s chips for the Chinese market are expected to be announced as early as next week. These chips come after Baidu ordered chips from Huawei instead of NVDA. Kevin Green discusses this, along with how Eli Lilly (LLY) gains FDA approval for a weight loss drug, Zepbound. Zepbound helped people lose 52 pounds in 16 months in clinical trials. Tune in to find out more about the stock market today.

Trading 360

09 Nov 2023

SHARE

ON AIR
3:00 pm
Market Overtime
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
education
5:00 am
Liz Ann Live
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Market Overtime
REPLAY
8:00 am
Market Overtime
REPLAY
8:30 am
Market On Close
REPLAY
education
10:00 am
Schwab 2026 Outlook
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Liz Ann Live
REPLAY
1:30 pm
The Wrap
REPLAY
ON AIR
3:00 pm
Market Overtime
REPLAY
4:00 pm
Market Overtime
REPLAY
4:30 pm
Market On Close
REPLAY
education
6:00 pm
Schwab 2026 Outlook
REPLAY
7:00 pm
Fast Market
REPLAY
8:00 pm
Next Gen Investing
REPLAY
education
9:00 pm
Liz Ann Live
REPLAY
9:30 pm
The Wrap
REPLAY
11:00 pm
Market Overtime
REPLAY

Schwab Network's Newsletters

Daily insights for every investor